SPIA
ALBO

Steward Partners Investment Advisory’s Albireo Pharma Inc ALBO Stock Holding History

Steward Partners Investment Advisory’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-900
Closed -$18K – 3471
2022
Q2 		$18K Buy
900
+200
+29% +$5.28K ﹤0.01% 2287
2022
Q1 		$21K Buy
+700
New +$20.5K ﹤0.01% 2353

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Steward Partners Investment Advisory's ALBO Position: Q3 2022 in Review

Steward Partners Investment Advisory sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 900 shares — an estimated $18K sold.

Steward Partners Investment Advisory first reported a position in ALBO in Q1 2022 and held it in 2 quarters. The position peaked at $21K in Q1 2022. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Steward Partners Investment Advisory reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 900 Albireo Pharma Inc shares in Q3 2022, an estimated $18K.
  • Steward Partners Investment Advisory first reported a position in Albireo Pharma Inc in Q1 2022 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Albireo Pharma Inc position peaked at $21K in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2022, filed 10 Nov 2022.